Mr. Singh has led U.S. Dermatology Partners since 2018, transforming the organization into one of the largest and most effective dermatology practices in the nation, now encompassing more than 120 locations across nine states and serving more than two million patients annually, with a compounded annual growth rate of over 20% in earnings. He has overseen the seamless integration of more than 65 acquisitions into a unified clinical care network, achieving a patient retention rate of 78% compared to a medical industry average of 43%, a 4.9-star average Google rating, and a Net Promoter Score of 80. A defining hallmark of his tenure is a cultural transformation that places physician autonomy, transparency and collaboration at the forefront, producing a physician retention rate of 94% since 2022 and a physician job satisfaction score of 4.3 out of 5.0, compared to the American Medical Association “Joy in Medicine” survey’s dermatology group average of 3.8. Mr. Singh has also driven significant research and access expansion, growing the U.S. Dermatology Partners Research Institute with a 150% increase in patient participation, a 466% increase in provider engagement and a 163% increase in clinical trials. Meanwhile, his outreach program has opened 48 new locations in rural and underserved communities, resulting in the diagnosis and care of over 38,000 skin cancer cases, more than 20,000 psoriasis cases and more than 115,000 cases of actinic keratosis. He serves as a board advisor for One Peak Medical and Adonis, is healthcare alumni president for the Dallas chapter of Harvard Business School’s medical school digital program, and is a member of the Young Presidents’ Organization Dallas chapter. Mr. Singh was named to D CEO‘s “Dallas 500” in 2024 and “Outstanding Healthcare Executive” in 2023. In 2026, Castle Connolly ranked U.S. Dermatology Partners the “No. 1 Dermatology Practice in the Nation.”
